“A compounded GHRP-6 product is FDA-approved.”

01 · Answer

Misleading

FDA says it does not approve compounded drugs. Its current 503A list puts GHRP-6 in Category 3. This means the nomination did not have enough support. FDA also lists safety concerns for 503B compounding. A 2019 warning letter said GHRP-6 did not meet the 503A rules in that case.

What kind of evidence this is

Regulatory or product record. This answer uses an official regulator record or a specific product label.

What this answer covers

U.S. FDA records about compounded GHRP-6, checked August 30, 2026. This is not legal advice about one product. This answer covers only the named molecule and finished product. It also covers the product form and how people used it. The study limits include who took part, what was used for comparison, what changed, and how long the study lasted.

Question type

Approval and status. Whether a specific product has an approval or another official status.